KALARIS THERAPEUTICS, INC. (KLRS) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading KLRS…

KALARIS THERAPEUTICS, INC. (KLRS) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

KALARIS THERAPEUTICS, INC.

KLRS · CIK 1754068

4 · Aug 28, 2026 · VP, Corporate Controller Vandekop Amy O'Leary was granted 10K Stock Option (Right to Buy)

4

VP, Corporate Controller Vandekop Amy O'Leary was granted 10K Stock Option (Right to Buy)

Filed: Aug 28, 2026
Period: Aug 27, 2026
Accession: 0001193125-26-374352
Filer: Kalaris Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov